The Food and Drug Administration released its 2013 annual report last week on the sale of medically important antibiotics to meat producers. The report shows that sales increased three percent in 2013, and 20 percent between 2009 and 2013.
The White House is expected to release an ambitious and comprehensive plan that would slow the deadly growth of antibiotic-resistant bacteria over the next five years. The plan will not only include huge monetary investments, but policy changes as well.
The microorganisms in the human gut can help the body to maintain a state of health. One problem with antibiotics, when used to fight pathogens, is that they can indiscriminately kill off beneficial bacteria. A new compound can help address this concern.
On Tuesday, Representative Louise Slaughter (D-NY) reintroduced the Preservation of Antibiotics for Medical Treatment Act (PAMTA), legislation that would ban the non-therapeutic use of eight important classes of antibiotics in food animal production.
Scientists are warning that some antibiotics can have an unintended impact on the microorganisms that live in an animal's gut. Ultimately this can affect the immune system, glucose metabolism, food absorption, obesity, stress and behavior.
After testing dust from in the air near large-scale feedlots on the Southern High Plains, scientists found evidence of antibiotics, feedlot-derived bacteria and DNA sequences that encode for antibiotic resistance.
Scientists are seeking to find out the different processes used by bacteria to survive destruction from antimicrobial peptides within the natural environment. The hope is to find new ways to kill pathogenic organisms.
The challenge faced by scientists in developing a new generation of antibiotics to challenge the menace of antibiotic resistant superbugs is considerable. To help with this, researchers have pinpointed the how resistance develops.
A British government-commissioned review has found that resistance to antibiotics could account for 10 million deaths a year and hit global gross domestic product by 2.0 to 3.5 percent by 2050.
Across the U.K., over 8,100 healthcare professionals and some 3,600 members of the public have pledged to do their own part to help reduce antibiotic resistance by becoming “antibiotic guardians.”
Technologists and biologists have combined resources to use computer simulations to show how bacteria are able to destroy antibiotics. This combination approach could lead to the development of a new generation of drugs.
If a patient contracts an infection while in the hospital, then each day of hospitalization increases the likelihood that the infection will be antibiotic resistant by one percent. This alarming finding comes from a new study.